Immune regulation by the gut microbiome at the maternal-fetal interface

母胎界面肠道微生物组的免疫调节

• 批准号: 10536170
• 负责人: Melody Y Zeng
• 金额: $ 43.73万
• 依托单位: WEILL MEDICAL COLL OF CORNELL UNIV
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-09-07 至 2025-08-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10536170
• 关键词: ARG2 gene; Affect; Antibiotics; Antibodies; Bacteria; Caring; Cells; Child; Coupled; Development; Diet; Down-Regulation; Exhibits; Fetal Development; Fetal Growth; Fetal Liver; Fetal Resorption; Fetal Tissues; Fetus; Future; Genes; Genetic; Germ-Free; Goals; Health; Human; Immune; Immune Tolerance; Immune response; Immune system; Immunoglobulin G; Incidence; Infection; Interferon Activation; Interferon Type II; Interferons; Intestines; Investigation; Lead; Malignant Neoplasms; Maternal-Fetal Exchange; Methodology; Mus; Myeloid-derived suppressor cells; Neonatal; Neutropenia; Newborn Infant; Pathway interactions; Pharmaceutical Preparations; Placenta; Placentation; Pre-Eclampsia; Predisposition; Pregnancy; Pregnancy Complications; Pregnancy Rate; Pregnant Women; Premature Birth; Regulation; Role; Shapes; Signal Transduction; Spiral Artery of the Endometrium; Spontaneous abortion; System; T-Lymphocyte; Techniques; Therapeutic Intervention; Tissues; United States; Uterus; fetal; genetic signature; gut bacteria; gut inflammation; gut microbiome; immunoregulation; imprint; in utero; interdisciplinary approach; murine colitis; neutrophil; novel; offspring; postnatal; pregnant; prenatal; progenitor; recruit; response; transcriptome; transcriptomics; trend

Despite advances in prenatal and maternal care, the incidence of pregnancy complications and preterm births remains high in the United States. Maternal immune tolerance toward the fetus is critical to promote fetal growth, but the regulatory mechanisms underlying fetal immune cell development remain largely undefined. Interferons are key regulators for placentation, but excessive interferon responses contribute to fetal resorption. In addition, maternal neutropenia is frequently associated with pregnancy complications such as preeclampsia, which has been demonstrated to affect the fetus and newborn adversely. Our understanding of the functions of neutrophils at the maternal-fetal interface, beyond their conventional role in infection, is still very limited. The gut microbiome undergoes drastic changes during pregnancy. However, the role of maternal gut microbiome immune tolerance and fetal immune regulation remains poorly understood. We have developed novel techniques to isolate and characterize placental immune cells in pregnant mice. Built upon our novel discovery of the maternal MDSC- IFNγ axis at the maternal-fetal interface that is orchestrated by the gut microbiome, the current proposal aims to define the role of maternal gut microbiome-driven MDSC-IFNγ axis in fetal and neonatal immune development. Leveraging the methodologies established in our lab to isolate and profile the transcriptome of immune cells, we will use an unbiased and comprehensive approach to fully appreciate functional changes in the fetal immune landscape due to perturbations of the gut microbiome. The transcriptomic studies will be coupled with ex vivo functional studies of tissue immune cells isolated from the placentas and fetal/neonatal intestines, as well as investigation of specific gut bacteria and metabolites that drive the immune cell changes at the maternal-fetal interface. First, we will employ an unbiased approach to profile the transcriptome of the fetal immune cells in the fetal liver and intestine to determine the role of the maternal MDSC-IFNγ axis in the regulation of immune cell development in these fetal tissues. Secondly, we will investigate how lacking maternal MDSCs during gestation impacts the postnatal immune development in the intestine, and investigate immune imprinting of T cells by in utero excessive IFNγ signaling and assess how it impacts the susceptibility to gut inflammation in the offspring. Upon completion, these studies will have defined the role of maternal gut microbiome, via regulation of the MDSC-IFNγ axis, shapes the fetal immune landscape and neonatal immune development in the intestine. Our studies will identify specific fetal immune subsets that are susceptible to perturbed MDSC-IFNγ axis that could be potential therapeutic/interventive targets. The findings from our studies will provide the framework for future studies of targeted manipulation of the gut microbiome to modulate these immune pathways to promote fetal immune cell development.

尽管产前和孕产妇护理进展，但怀孕并发症和早产的事件 在美国仍然很高。孕产妇对胎儿的免疫耐受性对于促进胎儿生长至关重要， 但是，胎儿免疫细胞发育的基本调节机制在很大程度上仍然不确定。干扰素 是用于胎盘的关键调节剂，但超过干扰素反应会导致胎儿解决。此外， 孕产妇中部症经常与妊娠并发症（例如先兆子痫）有关， 我们被证明会对胎儿和新生儿产生不利影响。我们对中性粒细胞功能的理解 在母亲界面上，除了在感染中的传统作用之外，仍然非常有限。肠道微生物组 怀孕期间发生急剧变化。但是，物物肠道微生物组免疫耐受的作用 胎儿免疫调节仍然很少理解。我们已经开发了新颖的技术来隔离和 表征孕妇的斑点免疫球。建立在我们对母亲MDSC-的新颖发现之上 由肠道微生物组策划的Mater-Fetal界面处的IFNγ轴，当前的建议旨在 定义母体肠道微生物组驱动的MDSC-IFNγ轴在胎儿和新生儿免疫发育中的作用。 利用我们实验室中建立的方法隔离和谱图免疫细胞的转录组，我们 将采用公正和全面的方法来充分理解胎儿免疫的功能变化 由于肠道微生物组的扰动而引起的景观。转录组研究将与离体结合 从子宫颈盐和胎儿/新生儿肠道分离的组织免疫细胞的功能研究以及 研究驱动免疫细胞变化的特定肠道细菌和代谢产物的特定肠道细菌和代谢物。 界面。首先，我们将采用一种公正的方法来介绍胎儿免疫细胞的转录组 胎儿肝脏和肠子确定母体MDSC-IFNγ轴在免疫细胞调节中的作用 这些胎儿组织的发育。其次，我们将调查妊娠期间缺乏MATER MDSC 影响肠后产后免疫发育，并通过IN研究T细胞的免疫印记 子宫过多的IFNγ信号传导和评估如何影响后代肠道注射的易感性。 完成后，这些研究将通过调节孕产妇肠道微生物组的作用 MDSC-IFNγ轴塑造肠道的胎儿免疫景观和新生儿免疫发育。我们的 研究将确定特定的胎儿免疫亚群，这些亚群易受扰动的MDSC-IFNγ轴 成为潜在的治疗/干预靶标。我们研究的发现将为未来提供框架 靶向操纵肠道微生物组的研究以调节这些免疫途径以促进胎儿 免疫细胞发育。